Abcam

This year at EACR, we were delighted to connect with many of our customers, gaining insights into their research and how they use Abcam products. Here, Serena Tondi from the Candiolo Cancer Institute shares her research on orthotopic pancreatic cancer and how Abcam products helped her analysis. “I'm Serena Tondi, a postdoctoral researcher at the Candiolo Cancer Institute in Turin. My research mainly focuses on pancreatic cancer, specifically on immune therapies. I developed an orthotopic pancreatic cancer model in mice, and I treat these tumors with different immune therapies, mainly CAR T cells. The goal is to reprogram the tumor microenvironment to improve the efficacy of CAR T cell therapy and create a more immuno-permissive environment. I use Abcam products during the analysis phase after tumor explant. At the end of the experiment, I remove the tumor and perform two types of analysis: flow cytometry on one side, and on the other, I use Abcam antibodies to stain tissue sections for immunofluorescence. I choose Abcam antibodies because, in my experience, they’ve provided the best performance. I’ve used antibodies targeting immune cell populations, especially the directly conjugated ones. After the analysis – particularly after acquisition – the image quality was excellent, and the product quality overall convinced me to keep using them. I have no negative feedback – so far, my experience has been very positive. I've used a small panel of antibodies, but my plan is to expand that panel for immunofluorescence and hopefully work more closely with you to build it out using additional antibodies.”

Join us in Boston this October for a 1-day conference dedicated to #mappingbiology to transform #cancertherapeutics. Registration is now open - visit the website to explore topics, confirmed speakers, and talk opportunities! https://lnkd.in/eAMgPrfg #MappingBiologytoTransformCancerTherapeutics2025

🔬 Join us on September 12 for a live symposium bringing together leading voices from academia and industry to share practical, actionable insights on antibody selection and validation – essential for robust and reproducible research. Chaired by Dr. Daniel Fazakerley Institute of Metabolic Science – University of Cambridge What to expect: ✅ 5 expert-led sessions ✅ Panel discussion ✅ Networking with lunch provided Featured talks: 🔹 Everything You Need to Know About Antibodies – Dr. Isabella Culotta, Abcam 🔹 The Path to Antibody Validation – Dr. Riham Ayoubi, McGill University / YCharOS 🔹 Accelerating Drug Discovery Through Better Antibody Practices – Dr. Carly Dix, AstraZeneca 🔹 Interactive: How to Choose the Right Antibody for Your Research – Dr. Carl Laflamme, McGill University / YCharOS 🔹 Abcam’s Commitment to High-Quality Antibodies – Dr. Ravindran Kumaran, Abcam 💬 Panel discussion: Antibody validation with speakers: – Dr. Daniel Fazakerley University of Cambridge – Dr. Michael S. Biddle, University of Leicester/YCharOS/OGA – Dr. Carly Dix, AstraZeneca – Hannah Cable, Abcam 📍 Location: Jeffrey Cheah Biomedical Centre, Cambridge 🍽️ Networking session with free lunch provided 👉 Don’t miss this opportunity to learn, connect, and elevate your research. #AntibodyValidation #Reproducibility #LifeSciences #DrugDiscovery #YCharOS #Abcam #AstraZeneca #ScientificResearch #OGA #CambridgeScience

Ever felt overwhelmed by antibody product data? 🧬 You’re not alone. Product data pages (PDPs) are full of useful info – but decoding them can feel like solving a puzzle. The trick? Knowing what to look for and where to ask questions. 👉 Want to make smarter antibody choices? Check out our quick guide to mastering PDPs and take the stress out of your search for the perfect antibody. https://bit.ly/41ifLIa

At a time when opportunities for trainees to share their science are harder to come by, Abcam is stepping up to create meaningful spaces for our early-career researchers in the Boston area to share their work! Register today for this free symposium Mon. Oct. 6, 2025 at the Harvard Longwood Medical Area and submit your abstract today for short talk and poster opportunities! 📢 Present your research at #MappingBiologytoTransformCancerTherapeutics2025 this October 6th, 2025 at the Harvard Longwood Medical Area in Boston. Complimentary registration is available until September 25th, and abstract submissions are welcome for short talks (by Sept 11) and posters (by Sept 25). View more details on the website 👉 https://lnkd.in/eEaMKu5V #ResearchOpportunity #Networking #MappingBiology #CancerTherapeutics #Abcam Abcam

Spend less time searching and more time discovering with our comprehensive antibody solutions. Designed to streamline your imaging workflow, our extensive catalog of reagents – validated in primary cell cultures and disease samples – enables you to simplify your workload and accelerate your research. Discover how we can simplify your AD research now: https://lnkd.in/emJwwr_a

This year at EACR, we were delighted to connect with many of our customers, gaining insights into their research and how they use Abcam products. Here, Berina from the Candiolo Cancer Institute shares her research on pancreatic cancer and how Abcam antibodies were used to identify CTCs: “My name is Berina Sabanovic, and I work at Candiolo Cancer Institute on pancreatic cancer. I’m isolating circulating tumor cells to identify cancer stem cells within this population. After positive identification, I perform single-cell RNA sequencing to discover novel targets that could support the development of personalized medicine. I’ve used Abcam antibodies for identifying CTCs. I worked with a panel of four antibodies, which helped pinpoint my population of interest – thanks to Abcam’s broad portfolio, especially their directly conjugated options. Since I needed four antibodies, the fluorochromes had to be spaced far apart, and Abcam’s catalog made that possible. My experience with Abcam has been very positive – both with this project and past ones. And whenever I’ve needed help with troubleshooting or contacted a specialist, the responses were always fast and relevant. So, keep up the great work. Thank you!” If you ever need support troubleshooting your experiment, our specialists are here for you - every step of the way. Because in science, the work never stops, and neither do we.

Save time, effort and money by choosing and validating the right antibody. Bringing together thought leaders from academia and industry, join us for a live symposium that explores practical solutions for finding and using antibodies to support robust and reproducible scientific research. 5 sessions, 4 keynote speakers: Chaired by Daniel Fazakerley, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge) – Everything you need to know about antibodies: Abcam – Isabella Culotta – The path to antibody validation: Lessons and challenges learned from the YCharOS Inc. initiative: Riham Ayoubi, McGill University (YCharOS) – Overcoming antibody selection, validation, and generation challenges to accelerate the discovery of new medicines: AstraZeneca – Carly Dix – Panel discussion on antibody validation (Featuring Michael S. Biddle University of Leicester YCharOS, Only Good Antibodies community) – How to choose the right antibody for your research: Carl Laflamme McGill University (YCharOS) – Abcam’s commitment to high quality antibodies: Abcam – Ravindran Kumaran Register here: https://bit.ly/41dqYJZ

Get antibodies that work first time, every time. Our enhanced IHC validation standard goes above and beyond. We validate up to 400 tissue cases for some of our best recombinant antibodies. https://bit.ly/3UZtIqN

Getting stuck setting up the right protocol and searching for a solution? We’ve all been there. Here’s Nathen from Abcam Scientific Support to show how you can get everything you need from our clear, comprehensive protocols quickly and efficiently. Check out all our protocols here: https://lnkd.in/gqbv2VGq